Alexandria Real Estate Equities has delivered a 427,000 RSF research and development facility for Bristol Myers Squibb at its San Diego megacampus. The new state-of-the-art R&D hub marks an operational milestone for the company and reflects demand from a large multinational pharmaceutical tenant. Alexandria Real Estate Equities focuses on life science and R&D campuses that serve large pharmaceutical and biotech companies, and this project adds scale to its megacampus model. The facility illustrates how purpose-built lab and R&D space can sit at the center of long-term relationships with global drug developers. For investors, the Bristol Myers Squibb hub may serve as a reference point for how fully built-out campuses can support leasing, development activity, and tenant retention.
Alexandria Real Estate Equities IncDelivered a 427,000 RSF R&D hub for Bristol Myers Squibb, demonstrating strong tenant demand and operational milestone.
Bristol-Myers Squibb CompanyReceived a new state-of-the-art R&D facility, expanding its operational capacity in San Diego.